HomeGLUE • NASDAQ
add
Monte Rosa Therapeutics Inc
Previous close
$9.35
Day range
$9.50 - $10.70
Year range
$3.50 - $12.40
Market cap
641.06M USD
Avg Volume
2.20M
P/E ratio
36.01
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 23.19M | 394.01% |
Operating expense | 9.70M | -16.85% |
Net income | -12.30M | 59.44% |
Net profit margin | -53.01 | 91.79% |
Earnings per share | -0.15 | 65.12% |
EBITDA | -13.43M | 56.09% |
Effective tax rate | -10.81% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 290.59M | 10.83% |
Total assets | 359.59M | 4.50% |
Total liabilities | 91.51M | -23.39% |
Total equity | 268.08M | — |
Shares outstanding | 61.76M | — |
Price to book | 2.15 | — |
Return on assets | -10.33% | — |
Return on capital | -12.42% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -12.30M | 59.44% |
Cash from operations | -34.72M | -25.04% |
Cash from investing | 25.32M | 141.41% |
Cash from financing | 365.00K | -99.63% |
Net change in cash | -9.03M | -199.26% |
Free cash flow | -24.07M | 0.84% |
About
Founded
2019
Headquarters
Website
Employees
142
